Tauriga Sciences, Inc. Sells Majority Stake of Pilus Energy Subsidiary to Open Therapeutics LLC
December 28, 2016 — New York, NY — Tauriga Sciences, Inc. (OTC PINK CURRENT TIER: TAUG) (“Tauriga” or the “Company”), a company engaged in building…
December 2016
Timothy Cripe, MD,PhD to present at the Onocolytic Virotherapy Summit 2016
Timothy Cripe, MD, PhD to present on preclinical and preliminary phase 1 clinical safety and efficacy studies of intravenously administered seprehvir, an onocolytic herpes viroimmunotherapeutic.…
